Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.
Emily C SomersGregory A EschenauerJonathan P TroostJonathan L GolobTejal N GandhiLu WangNina ZhouLindsay A PettyJi Hoon BaangNicholas O DillmanDavid FrameKevin S GreggDan R KaulJerod NagelTwisha S PatelShiwei ZhouAdam S LauringDavid A HanauerEmily MartinPratima SharmaChristopher M FungJason M PoguePublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
In this cohort of mechanically ventilated COVID-19 patients, tocilizumab was associated with lower mortality despite higher superinfection occurrence.
Keyphrases
- rheumatoid arthritis
- intensive care unit
- acute respiratory distress syndrome
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- risk assessment
- sars cov
- cardiovascular events
- disease activity
- cardiovascular disease
- extracorporeal membrane oxygenation
- coronary artery disease
- combination therapy
- systemic lupus erythematosus